Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Mimedx (MDXG) over the last 11 years, with Q3 2025 value amounting to -$126000.0.

  • Mimedx's Non Operating Income fell 50000.0% to -$126000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$580000.0, marking a year-over-year decrease of 7008.8%. This contributed to the annual value of -$565000.0 for FY2024, which is 207307.69% down from last year.
  • Latest data reveals that Mimedx reported Non Operating Income of -$126000.0 as of Q3 2025, which was down 50000.0% from -$101000.0 recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Non Operating Income peaked at $16000.0 during Q4 2023, and registered a low of -$237000.0 during Q2 2024.
  • Moreover, its 5-year median value for Non Operating Income was -$26500.0 (2023), whereas its average is -$70571.4.
  • Per our database at Business Quant, Mimedx's Non Operating Income skyrocketed by 63333.33% in 2023 and then plummeted by 505000.0% in 2024.
  • Quarter analysis of 5 years shows Mimedx's Non Operating Income stood at -$20000.0 in 2021, then skyrocketed by 85.0% to -$3000.0 in 2022, then skyrocketed by 633.33% to $16000.0 in 2023, then crashed by 1400.0% to -$208000.0 in 2024, then soared by 39.42% to -$126000.0 in 2025.
  • Its Non Operating Income stands at -$126000.0 for Q3 2025, versus -$101000.0 for Q2 2025 and -$145000.0 for Q1 2025.